Technology
Health
Biotechnology

Summit Therapeutics

$1.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (6.21%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SMMT and other stocks, options, ETFs, and crypto commission-free!

About

Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company operates through the Drug Development segment, which covers its research and development activities carried out by the Group. Read More Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom.

Employees
61
Headquarters
Abingdon, Oxfordshire
Founded
2004
Market Cap
51.65M
Price-Earnings Ratio
2.86
Dividend Yield
Average Volume
88.25K
High Today
$1.72
Low Today
$1.67
Open Price
$1.69
Volume
5.96K
52 Week High
$14.12
52 Week Low
$1.10

Collections

Technology
Health
Biotechnology
Therapy
Research And Development
2015 IPO
UK
Europe

News

Yahoo FinanceMay 7

Does Summit Therapeutics plc's (LON:SUMM) CEO Pay Matter?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Glyn Edwards has been the CEO of Summit Therapeutics plc (LON:SUMM) since 2012. First, this article will compare CEO compensation with compensation at similar sized companies. Then we'll look at a snap shot of the business growth. And finally we will reflect on how common stockholders have fared in the last few years, as a secondary measure of performance. This process should give us ...

40

Earnings

-$0.53
-$0.21
$0.10
$0.42
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Jun 4, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.